Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results , but sales were flat year on year at $1.1 billion. On the ...

The company forecast annual revenue of $4.28 billion to $4.4 billion for 2025, the midpoint of which is below analysts' ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Genomic sequencing specialist Illumina (NASDAQ: ILMN) was something of a victim in the U.S.-China trade spat on Tuesday.

US President Donald Trump and Chinese leader Xi Jinping are set soon to hold a high-stakes phone call on the tit-for-tat ...

KEY TAKEAWAYSChina retaliated against new U.S. tariffs soon after they took effect Tuesday, imposing duties on the imports of ...

Authorities also put Calvin Klein owner PVH and US gene sequencing company Illumina onto a so-called blacklist of entities ...

Bosses of big technology firms may find reassurance in comparing artificial intelligence to a lump of coal. Claimed ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a look at where Illumina, Inc.

Over the last 20 years, precision medicine has become the standard of care, but for many hospitals, the complexity of the ...

The next leap in AI-driven healthcare requires brain power, a huge investment of money, and the courage to implement.